✦ LIBER ✦

The ATAC (Arimidex™, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal (PM) patients (pts): Factors influencing the success of PT recruitment

✍ Scribed by M. Baum

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The ATAC (Arimidex™, Tamoxifen, Alone or

✍ Mike Baum 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 69 KB

3–38 Quality of Life of Postmenopausal W

✍ Vassilopoulou-Sellin, R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Assessing the quality of life of postmen

✍ L. Fallowfield; D. Cella 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 223 KB

The ATAC (Arimidex, Tamoxifen, alone or

✍ J. Tobias 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Molecular markers in the endometrium at

✍ Sean R.G. Duffy; Lydia Taylor 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Results of the ATAC (Arimidex, Tamoxifen

📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 66 KB